Close Menu

single-cell genomics

Correction: The story has been updated to include the correct net proceed amount from the sale. NEW YORK (GenomeWeb News) – Fluidigm said after the close of the market on Tuesday it has closed on the sale of about $201.3 million of senior convertible notes.

NanoString Technologies last week reported a 39 percent increase in third quarter revenues while company executives offered an overview of the Seattle-based company's opportunities in the molecular diagnostics and life science research markets.

Fluidigm continues to expand the menu of applications that can be run on single cells prepared for analysis on its C1 Single-Cell AutoPrep System.

NanoString Technologies is no newcomer to the single-cell genomics market. The firm last year launched a single-cell gene expression assay for use on its nCounter Analysis System.

NEW YORK (GenomeWeb News) – NanoString Technologies and BD segment BD Biosciences today announced a collaboration to develop a single-cell isolation and analysis workflow.

This story was originally posted on Aug. 2.
Fluidigm last week raised its full-year 2013 guidance after posting 36 percent second-quarter revenue growth, largely due to increasing demand for its single-cell genomics products.

Fluidigm said this week that single-cell genomics applications and production genotyping continued to serve as the primary growth drivers for the company, helping first-quarter revenues spike 33 percent year over year.

SINGAPORE — A new center located in this Asian city-state should expand regional single-cell biology research efforts and aid in the development of new diagnostics and therapies, according to its founders.

By encapsulating single organisms from microbiome samples in gel microdroplets and then culturing them to form microcolonies, researchers from the Los Alamos National Laboratory have been able to sequence the genomes of individual bacterial species with much higher coverage and l

Star Array, a spinout of Singapore's Nanyang Technological University, has developed a microfluidic liquid-phase nucleic acid purification chip that can selectively isolate DNA or RNA from low numbers of cells in minute sample volumes, and subsequently PCR amplify the purified nu

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.